Investment into molecular diagnostics company makes perfect Sense

Mercia Fund Management (Mercia) has underlined its commitment to pursue investment in the burgeoning diagnostics sector by investing early stage capital in Sense Biodetection Limited (Sense). The investment will allow Sense to develop its initial product – point-of-care diagnostic tests within the infectious diseases market. Experienced angel investor and former CEO of the Bank of

Mercia-backed Particle Analytics wins double in awards celebrating entrepreneurship in Scotland

Particle Analytics, a start-up within Mercia’s SEIS portfolio that builds on world-renowned solid particle technology from the University of Edinburgh, has won two separate awards in the space of two weeks, both of which celebrate entrepreneurship and innovation in Scotland. The company won ‘Spinout of the Year’ at the Inspire Launch Grow competition organised by

Enterprise Ventures backs buy-in at North’s leading blinds company

The North’s leading supplier of commercial blinds has changed hands in a management buy-in backed by Enterprise Ventures. The deal allows Rod Roberts-Dear to take control of Dearnleys in Wakefield and its sister company Pentel Contracts in Salford. Mr Roberts-Dear, whose previous roles include Managing Director within the automotive group Inchcape and Marketing Director of

Focus, build, deliver: the healthy approach to life sciences

Life sciences offers a broad range of subsectors that are potentially rewarding to both business builders and investors, particularly as technologies converge to include bio and advanced materials, connectivity and digital innovations across the UK. In the wake of global challenges, including Zika, antimicrobial resistance, an ageing population and demographics growth, technological advances in surgery

Investment sets stage for further growth at Blue-i

A company which provides technical staging for TV, West End theatre shows and high-profile events has received a seven-figure equity investment from Enterprise Ventures Growth Fund to help fuel its expansion. Blue-I is one of the UK’s leading suppliers of video projection, high-resolution displays and audio and lighting to the live events industry. Its recent

“Plastic antibody” developer secures customers after only one year of operation; Receives follow-on investment

[Pictured: Adrian Kinkaid receiving an award for the Dragon’s Den competition at the ELRIG Drug Discovery Conference, held in September 2015.] MIP Diagnostics Ltd, a spinout from the University of Leicester developing plastic antibodies for a variety of applications, has received follow-on investment from Mercia Fund Management (Mercia), a leading investment business in UK innovation